HomeCompareMGLN vs JEPQ

MGLN vs JEPQ: Dividend Comparison 2026

MGLN yields 2.11% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JEPQ wins by $22.0K in total portfolio value
10 years
MGLN
MGLN
● Live price
2.11%
Share price
$94.99
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$241.25
Full MGLN calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — MGLN vs JEPQ

📍 JEPQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMGLNJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MGLN + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MGLN pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MGLN
Annual income on $10K today (after 15% tax)
$178.97/yr
After 10yr DRIP, annual income (after tax)
$205.06/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, JEPQ beats the other by $1,624.64/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MGLN + JEPQ for your $10,000?

MGLN: 50%JEPQ: 50%
100% JEPQ50/50100% MGLN
Portfolio after 10yr
$33.8K
Annual income
$1,196.91/yr
Blended yield
3.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MGLN right now

MGLN
Analyst Ratings
6
Buy
4
Hold
2
Sell
Consensus: Buy
JEPQ
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MGLN buys
0
JEPQ buys
0
No recent congressional trades found for MGLN or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMGLNJEPQ
Forward yield2.11%11.10%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$22.8K$44.8K
Annual income after 10y$241.25$2,152.59
Total dividends collected$2.3K$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: MGLN vs JEPQ ($10,000, DRIP)

YearMGLN PortfolioMGLN Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$10,911$210.55$11,930$1,110.39$1.0KJEPQ
2$11,889$214.69$14,133$1,224.34$2.2KJEPQ
3$12,940$218.64$16,632$1,340.46$3.7KJEPQ
4$14,068$222.40$19,454$1,457.97$5.4KJEPQ
5$15,279$225.97$22,626$1,576.08$7.3KJEPQ
6$16,578$229.36$26,175$1,694.09$9.6KJEPQ
7$17,971$232.58$30,133$1,811.32$12.2KJEPQ
8$19,464$235.63$34,531$1,927.17$15.1KJEPQ
9$21,065$238.52$39,403$2,041.08$18.3KJEPQ
10$22,781$241.25$44,787$2,152.59$22.0KJEPQ

MGLN vs JEPQ: Complete Analysis 2026

MGLNStock

Magellan Health, Inc., together with its subsidiaries, provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans; and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Further, it offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions. In addition, the company provides services to health plans and managed care organizations, employers, labor unions, third party administrators, state governments, military and governmental agencies, exchanges, brokers, and consultants. Magellan Health, Inc. was incorporated in 1969 and is headquartered in Phoenix, Arizona. As of January 4, 2022, Magellan Health, Inc. operates as a subsidiary of Centene Corporation.

Full MGLN Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this MGLN vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MGLN vs SCHDMGLN vs JEPIMGLN vs OMGLN vs KOMGLN vs MAINMGLN vs XYLDMGLN vs QYLDMGLN vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.